ReviewInfection and drug resistance2026
Yellow Fever, an Arboviral Disease with Public Health Impacts: General Aspects and the Use of the One Health Approach in the Context of This Zoonosis.
Review in Infection and drug resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Yellow fever is a long-standing zoonotic arboviral disease that affects hundreds of thousands of people annually in different regions of the world, even though the vaccine has been available since the 1930s. Thus, studies that synthesize general and current information on yellow fever are relevant, aiming to disseminate knowledge that can contribute to mitigating its impacts. This narrative review synthesizes the general aspects of yellow fever, discusses its impacts on public health, and presents information on the use of the One Health approach in the context of this zoonosis. The databases used to select the articles were PubMed, Scopus, LILACS, and SciELO, using various descriptors related to the study's theme and objectives. It is important to highlight that yellow fever remains a significant public health challenge due to its high mortality rate in severe cases and the continued circulation of the yellow fever virus in tropical areas, especially in South America and Africa. Although many patients recover spontaneously, recurrent outbreaks continue in endemic regions. The initial clinical similarity to other zoonoses makes timely diagnosis difficult, and management remains restricted to clinical support, as there is no specific antiviral treatment. Vaccination and epidemiological surveillance stand out as the main preventive measures. Additionally, considering that the management of yellow fever involves human, animal, and environmental health aspects, the One Health approach stands out as a modern, robust, and effective alternative for addressing this zoonosis. However, the lack of knowledge regarding this approach among public managers and health professionals results in its non-use and, consequently, impacts the fight against yellow fever. Therefore, it is important to widely disseminate knowledge about the One Health approach, aiming at carrying out holistic actions in the human-animal-environmental interface sectors in the context of yellow fever, allowing for coordinated and sustainable responses at different levels and instances.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.